Published in PLoS One on April 23, 2008
AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 10.42
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal (2012) 5.65
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A (2010) 3.03
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol (2009) 1.52
AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther (2013) 1.28
Mitochondria and reactive oxygen species. Hypertension (2009) 1.19
Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation. Cell Death Differ (2012) 1.19
PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Cell (2012) 1.11
Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS One (2012) 1.09
A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS One (2013) 1.09
TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res (2013) 1.08
Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J Biol Chem (2012) 1.08
The role of ATM in response to metformin treatment and activation of AMPK. Nat Genet (2012) 1.06
Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLoS One (2012) 1.02
Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. Aging (Albany NY) (2011) 1.01
Role of AMPK in UVB-induced DNA damage repair and growth control. Oncogene (2012) 0.96
High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model. PLoS One (2011) 0.95
Tug of war between survival and death: exploring ATM function in cancer. Int J Mol Sci (2014) 0.92
Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med (2012) 0.92
Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma. Proc Natl Acad Sci U S A (2009) 0.92
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J Gastroenterol (2010) 0.92
ATM and LKB1 dependent activation of AMPK sensitizes cancer cells to etoposide-induced apoptosis. Cancer Lett (2012) 0.89
ATM protects against oxidative stress induced by oxidized low-density lipoprotein. DNA Repair (Amst) (2011) 0.88
Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres. PLoS One (2014) 0.88
World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1. Diabetes Care (2011) 0.85
Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling. Am J Pathol (2011) 0.84
Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. Arch Biochem Biophys (2009) 0.83
Kinetics of the cell biological changes occurring in the progression of DNA damage-induced senescence. Mol Cells (2011) 0.83
The thyroid hormone receptor β induces DNA damage and premature senescence. J Cell Biol (2014) 0.82
AMPK as a potential anticancer target - friend or foe? Curr Pharm Des (2014) 0.82
Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death Dis (2015) 0.81
Endothelium under stress: local and systemic messages. Semin Nephrol (2012) 0.81
The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection. Yale J Biol Med (2012) 0.81
Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts. Radiat Oncol (2012) 0.80
Mitochondrial reactive oxygen species-mediated genomic instability in low-dose irradiated human cells through nuclear retention of cyclin D1. Cell Cycle (2016) 0.80
Radiation induces senescence and a bystander effect through metabolic alterations. Cell Death Dis (2014) 0.80
Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53. Sci Rep (2015) 0.79
Low-dose etoposide-treatment induces endoreplication and cell death accompanied by cytoskeletal alterations in A549 cells: Does the response involve senescence? The possible role of vimentin. Cancer Cell Int (2013) 0.79
Severe mitochondrial damage associated with low-dose radiation sensitivity in ATM- and NBS1-deficient cells. Cell Cycle (2016) 0.79
Chloroquine increases phosphorylation of AMPK and Akt in myotubes. Heliyon (2016) 0.78
Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population. BMC Med Genet (2008) 0.78
Mitochondrial protein-linked DNA breaks perturb mitochondrial gene transcription and trigger free radical-induced DNA damage. Sci Adv (2017) 0.77
Maintenance of mitochondrial DNA by the Caenorhabditis elegans ATR checkpoint protein ATL-1. Genetics (2008) 0.77
The role of ATM in response to metformin treatment and activation of AMPK. Nat Genet (2012) 0.77
Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis. Biochim Biophys Acta (2011) 0.77
AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks. Oncotarget (2016) 0.77
Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials. Oncotarget (2017) 0.76
Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches. Oncotarget (2015) 0.76
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism. Mol Cells (2015) 0.76
Altered Mitochondrial Signalling and Metabolism in Cancer. Front Oncol (2017) 0.75
Etoposide induced cytotoxicity mediated by ROS and ERK in human kidney proximal tubule cells. Sci Rep (2016) 0.75
A new live-cell reporter strategy to simultaneously monitor mitochondrial biogenesis and morphology. Sci Rep (2015) 0.75
AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway. Int J Oncol (2016) 0.75
Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA. Proc Natl Acad Sci U S A (2016) 0.75
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (2003) 20.13
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev (2001) 12.46
Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell (1996) 10.40
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol (2003) 9.14
Mitochondrial DNA mutations in human disease. Nat Rev Genet (2005) 8.51
Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab (2005) 8.30
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A (2007) 8.23
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature (2004) 7.21
5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem (1995) 7.12
Towards a molecular understanding of adaptive thermogenesis. Nature (2000) 7.04
The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem (2005) 6.27
AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A (2002) 5.93
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell (2006) 5.58
The many substrates and functions of ATM. Nat Rev Mol Cell Biol (2000) 5.46
AMP-activated protein kinase--development of the energy sensor concept. J Physiol (2006) 4.93
Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci U S A (2003) 4.87
The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci (2006) 4.67
Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature (1975) 4.30
Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell (2007) 4.30
Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science (2002) 4.18
Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A (1996) 3.78
Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A (1994) 3.46
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy (2007) 3.14
Recombinant ATM protein complements the cellular A-T phenotype. Oncogene (1997) 2.95
Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell (2005) 2.89
Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet (1997) 2.75
Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem (2006) 2.69
Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett (1994) 2.65
Leukemia and lymphoma in ataxia telangiectasia. Blood (1996) 2.65
Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol (2005) 2.46
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A (2004) 2.44
Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) (2004) 2.35
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) (2002) 2.30
Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res (2000) 2.22
The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol (2006) 2.19
Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst (1986) 2.14
Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J Clin Invest (2007) 2.03
Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol Cell Biol (2004) 1.97
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89
Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol (2006) 1.72
AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner. Mol Cell Biochem (2007) 1.65
Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J Immunol (2007) 1.62
Transcription and replication of animal mitochondrial DNAs. Int Rev Cytol (1992) 1.58
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem (2002) 1.54
Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet (2004) 1.50
Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res (2004) 1.43
Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol (2002) 1.42
A protease pathway for the repair of topoisomerase II-DNA covalent complexes. J Biol Chem (2006) 1.41
Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis (2005) 1.37
Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet (2007) 1.37
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med (1978) 1.37
IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. Biochem Biophys Res Commun (2004) 1.34
Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase. Cell Cycle (2007) 1.34
Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair (Amst) (2006) 1.32
Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal (2002) 1.21
Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child (1967) 1.19
Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann Neurol (2001) 1.18
Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene (2004) 1.17
DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem (2003) 1.15
G-quadruplexes induce apoptosis in tumor cells. Cancer Res (2006) 1.14
Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic Biol Med (2004) 1.12
Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc Natl Acad Sci U S A (1997) 1.11
Oxidative stress-induced depolymerization of microtubules and alteration of mitochondrial mass in human cells. Ann N Y Acad Sci (2005) 1.10
Nuclear genes in mitochondrial disorders. Curr Opin Genet Dev (2003) 1.10
Ataxia-telangiectasia: founder effect among north African Jews. Hum Mol Genet (1996) 1.05
Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet (1990) 1.03
Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells. Biochem Biophys Res Commun (2004) 1.02
Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol (1999) 1.01
Evolution of cellular ATP concentration after UV-mediated induction of SOS system in Escherichia coli. Biochem Biophys Res Commun (1983) 1.00
Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet (1990) 1.00
Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. Exp Cell Res (1995) 0.96
Mitochondrial disorders. Curr Opin Neurol (2003) 0.95
Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology (2003) 0.94
Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. J Bioenerg Biomembr (2007) 0.90
Radiation reaction in ataxia telangiectasia. Am J Dis Child (1968) 0.90
Imparied glutathione biosynthesis in cultured human ataxia-telangiectasia cells. Cancer Res (1987) 0.87
Changes in ATP concentration in Escherichia coli during induction of the SOS system by mitomycin C and bleomycin. J Gen Microbiol (1984) 0.85
Identification of a neurite outgrowth-promoting motif within the alternatively spliced region of human tenascin-C. J Neurosci (2001) 0.84
Mitochondrial function and dysfunction within the optic nerve. Arch Ophthalmol (2003) 0.84
VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res (1989) 0.84
Autoimmune phenomena in ataxia telangiectasia. J Pediatr (1971) 0.83
The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells. Arch Biochem Biophys (2002) 0.81
The immunological deficiency state in ataxia-telangiectasia. Res Publ Assoc Res Nerv Ment Dis (1971) 0.80
Selective cytotoxicity of benzyl isothiocyanate in the proliferating fibroblastoid cells. Int J Cancer (2007) 0.80
Ataxia-telangiectasia: genetics, neuropathology, and immunology of a degenerative disease of childhood. Proceedings of a conference. Solvang, California, January 16-20, 1984. Kroc Found Ser (1985) 0.77
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med (2012) 3.20
The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy (2007) 3.14
5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity. Bioorg Med Chem (2003) 3.13
Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today (2006) 2.59
Autophagy regulates ageing in C. elegans. Autophagy (2007) 2.22
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci U S A (2007) 1.92
Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res (2007) 1.83
Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol (2006) 1.70
Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J Biol Chem (2004) 1.66
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res (2006) 1.59
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol Cell Biol (2003) 1.43
A protease pathway for the repair of topoisomerase II-DNA covalent complexes. J Biol Chem (2006) 1.41
A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes. J Biol Chem (2008) 1.31
Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Res (2003) 1.26
Schizosaccharomyces pombe pfh1+ encodes an essential 5' to 3' DNA helicase that is a member of the PIF1 subfamily of DNA helicases. Mol Biol Cell (2002) 1.23
Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J Biol Chem (2006) 1.23
Dual localization of human DNA topoisomerase IIIalpha to mitochondria and nucleus. Proc Natl Acad Sci U S A (2002) 1.19
ISG15 as a novel tumor biomarker for drug sensitivity. Mol Cancer Ther (2008) 1.19
The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Proc Natl Acad Sci U S A (2003) 1.18
Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death. J Biol Chem (2003) 1.17
DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem (2003) 1.15
G-quadruplexes induce apoptosis in tumor cells. Cancer Res (2006) 1.14
Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks. J Biol Chem (2009) 1.11
Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS One (2012) 1.09
Inactivation of Cdc13p triggers MEC1-dependent apoptotic signals in yeast. J Biol Chem (2003) 1.08
Nuclear translocation of cytochrome c during apoptosis. J Biol Chem (2004) 1.06
Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents. Bioorg Med Chem (2003) 1.05
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med (Maywood) (2011) 1.03
Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals. J Biol Chem (2003) 1.01
Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res (2006) 0.99
5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance. J Med Chem (2005) 0.97
Comparison of QTL controlling seedling vigour under different temperature conditions using recombinant inbred lines in rice (Oryza sativa). Ann Bot (2004) 0.96
Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity. J Med Chem (2003) 0.93
Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity. Bioorg Med Chem (2005) 0.92
Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIα. J Biol Chem (2011) 0.92
A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway. PLoS One (2011) 0.91
Interferon-β signaling contributes to Ras transformation. PLoS One (2011) 0.89
Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. PLoS One (2012) 0.89
Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol. J Cell Biochem (2013) 0.88
Acidic pH induces topoisomerase II-mediated DNA damage. Proc Natl Acad Sci U S A (2003) 0.87
A G-quadruplex stabilizer induces M-phase cell cycle arrest. J Biol Chem (2009) 0.87
Macrocyclic hexaoxazoles: Influence of aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity. Bioorg Med Chem Lett (2010) 0.87
Protection of DNA ends by telomeric 3' G-tail sequences. J Biol Chem (2007) 0.85
TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues. Oncol Lett (2013) 0.83
Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents. Bioorg Med Chem (2008) 0.83
Ring-closing metathesis for the synthesis of a highly G-quadruplex selective macrocyclic hexaoxazole having enhanced cytotoxic potency. Bioorg Med Chem Lett (2008) 0.82
6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity. Bioorg Med Chem (2006) 0.82
Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435. Bioorg Med Chem Lett (2002) 0.82
Role of DNA topoisomerase IIbeta in neurite outgrowth. Brain Res (2007) 0.82
Topoisomerase IIbeta is required for proper retinal development and survival of postmitotic cells. Biol Open (2014) 0.81
Topoisomerase IIβ deficiency enhances camptothecin-induced apoptosis. J Biol Chem (2013) 0.81
The antiaging activity and cerebral protection of rapamycin at micro-doses. CNS Neurosci Ther (2014) 0.80
Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents. Bioorg Med Chem (2005) 0.80
Isodiospyrin as a novel human DNA topoisomerase I inhibitor. Biochem Pharmacol (2003) 0.79
Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents. Bioorg Med Chem (2003) 0.79
11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity. Bioorg Med Chem (2004) 0.79
Macrocyclic biphenyl tetraoxazoles: synthesis, evaluation as G-quadruplex stabilizers and cytotoxic activity. Bioorg Med Chem (2013) 0.79
Structure and topology of Slc11a1(164-191) with G169D mutation in membrane-mimetic environments. J Struct Biol (2008) 0.78
Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock. Mol Cell Biol (2013) 0.78
Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity. Bioorg Med Chem Lett (2004) 0.78
Structure analysis of the fourth transmembrane domain of Nramp1 in model membranes. Biochim Biophys Acta (2008) 0.78
Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS One (2013) 0.78
Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31). Bioorg Med Chem (2008) 0.78
A novel synthetic bipartite carrier protein for developing glycotope-based vaccines. Vaccine (2012) 0.77
8,9-methylenedioxybenzo[i]phenanthridines: topoisomerase I-targeting activity and cytotoxicity. Bioorg Med Chem (2003) 0.77
microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer. J Exp Clin Cancer Res (2013) 0.77
TOR regulates cell death induced by telomere dysfunction in budding yeast. PLoS One (2008) 0.77
Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates. Bioorg Med Chem Lett (2008) 0.77
Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity. J Med Chem (2006) 0.76
Cytotoxicity and TOP1-targeting activity of 8- and 9-amino derivatives of 5-butyl- and 5-(2-N,N-dimethylamino)ethyl-5H-dibenzo[c,h][1,6]naphthyridin-6-ones. Eur J Med Chem (2008) 0.76
Analysis of Retinal Development and Diseases Using RNA-Seq. Cell Dev Biol (2012) 0.76
Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Biochem Biophys Res Commun (2010) 0.76
12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents. Bioorg Med Chem (2009) 0.75
Early and late urodynamic assessment of the orthotopic N-shaped neobladder. Oncol Lett (2013) 0.75
Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide. Eur J Med Chem (2009) 0.75
Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells. Oncol Rep (2011) 0.75
11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents. Bioorg Med Chem (2008) 0.75